Biohaven (BHVN) Share-based Compensation (2021 - 2026)

Biohaven has reported Share-based Compensation for 6 years, with the latest figure at $28.3 million in Q1 2026.

• Quarterly Share-based Compensation fell 46.69% year-over-year to $28.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $70.6 million (down 21.65% YoY) and the FY2024 annual result came in at $72.0 million, changed N/A from the prior year.
• Share-based Compensation improved to $28.3 million in Q1 2026 per BHVN's latest filing, from $21.5 million in the prior quarter.
• Over five years, Share-based Compensation peaked at $101.4 million in Q4 2022 and troughed at $1.8 million in Q1 2022.
• A 5-year average of $27.4 million and a median of $18.9 million in 2022 frame the typical range for Share-based Compensation.
• The sharpest annual moves came in 2022 and 2023: Share-based Compensation jumped 682.23% in 2022, then tumbled 92.06% in 2023.
• Over 5 years, Share-based Compensation stood at $101.4 million in 2022, then tumbled by 95.61% to $4.5 million in 2023, then soared by 184.87% to $12.7 million in 2024, then soared by 69.65% to $21.5 million in 2025, then jumped by 31.35% to $28.3 million in 2026.
• According to Business Quant data, Share-based Compensation over the past three periods registered $28.3 million, $21.5 million, and $20.8 million for Q1 2026, Q3 2025, and Q2 2025 respectively.